Literature DB >> 14757931

Transferrin C2 variant does confer a risk for Alzheimer's disease in caucasians.

Pamela Zambenedetti1, GianLuca De Bellis, Ida Biunno, Massimo Musicco, Paolo Zatta.   

Abstract

Several gene mutations are associated with an increased risk of Alzheimer's disease. Previous studies reported higher transferrin C2 allele frequencies in Alzheimer's disease compared with normal controls. However, potential interactions between transferrin C2 and APOE (epsilon 4), have not been extensively investigated and have been the subject of controversial reports from several laboratories. We have carried out a case-control study on the association between Alzheimer's disease and transferrin C2 and APOE epsilon 4 alleles. epsilon 4 allele was associated with a four fold increase in the risk of disease, and transferrin C2 allele was significantly associated with Alzheimer's disease only in epsilon 4 negative subjects. These results suggest that apoE and transferrin may be part of a complex mechanism in the pathogenesis of Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14757931     DOI: 10.3233/jad-2003-5601

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  13 in total

Review 1.  Iron-chelating backbone coupled with monoamine oxidase inhibitory moiety as novel pluripotential therapeutic agents for Alzheimer's disease: a tribute to Moussa Youdim.

Authors:  Orly Weinreb; Silvia Mandel; Orit Bar-Am; Tamar Amit
Journal:  J Neural Transm (Vienna)       Date:  2011-03-01       Impact factor: 3.575

2.  Suggestive synergy between genetic variants in TF and HFE as risk factors for Alzheimer's disease.

Authors:  J S K Kauwe; S Bertelsen; K Mayo; C Cruchaga; R Abraham; P Hollingworth; D Harold; M J Owen; J Williams; S Lovestone; J C Morris; A M Goate
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2010-06-05       Impact factor: 3.568

3.  The characteristics of transferrin variants by carbohydrate-deficient transferrin tests using capillary zone electrophoresis.

Authors:  Gilsung Yoo; Juwon Kim; Kap Joon Yoon; Jong-Han Lee
Journal:  J Clin Lab Anal       Date:  2018-04-17       Impact factor: 2.352

Review 4.  Amyloid precursor protein and alpha synuclein translation, implications for iron and inflammation in neurodegenerative diseases.

Authors:  Catherine M Cahill; Debomoy K Lahiri; Xudong Huang; Jack T Rogers
Journal:  Biochim Biophys Acta       Date:  2008-12-29

Review 5.  Pathology supported genetic testing and treatment of cardiovascular disease in middle age for prevention of Alzheimer's disease.

Authors:  Maritha J Kotze; Susan J van Rensburg
Journal:  Metab Brain Dis       Date:  2012-04-19       Impact factor: 3.584

6.  Issues raised involving the copper hypotheses in the causation of Alzheimer's disease.

Authors:  George J Brewer
Journal:  Int J Alzheimers Dis       Date:  2011-09-14

7.  Alzheimer's disease causation by copper toxicity and treatment with zinc.

Authors:  George J Brewer
Journal:  Front Aging Neurosci       Date:  2014-05-16       Impact factor: 5.750

8.  Polymorphisms in the genes coding for iron binding and transporting proteins are associated with disability, severity, and early progression in multiple sclerosis.

Authors:  Donato Gemmati; Giulia Zeri; Elisa Orioli; Francesca E De Gaetano; Fabrizio Salvi; Ilaria Bartolomei; Sandra D'Alfonso; Claudia Dall'osso; Maurizio A Leone; Ajay V Singh; Rosanna Asselta; Paolo Zamboni
Journal:  BMC Med Genet       Date:  2012-08-10       Impact factor: 2.103

Review 9.  Zinc deficiency and zinc therapy efficacy with reduction of serum free copper in Alzheimer's disease.

Authors:  George J Brewer; Sukhvir Kaur
Journal:  Int J Alzheimers Dis       Date:  2013-10-10

10.  Biological consequences of zinc deficiency in the pathomechanisms of selected diseases.

Authors:  Kamil Jurowski; Bernadeta Szewczyk; Gabriel Nowak; Wojciech Piekoszewski
Journal:  J Biol Inorg Chem       Date:  2014-04-19       Impact factor: 3.358

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.